Free Trial
→ Trump’s Bitcoin Reserve is No Accident… (From Crypto 101 Media) (Ad) Buy CCAP Stock  Free CCAP Stock Alerts

Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC logo
$15.51 -0.05 (-0.32%)
Closing price 04:00 PM Eastern
Extended Trading
$15.61 +0.10 (+0.67%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Crescent Capital BDC

Annual Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Net Income / (Loss) Attributable to Common Shareholders		 -16 0.26 -43 84
Consolidated Net Income / (Loss)		 -16 0.26 -43 79
Net Income / (Loss) Continuing Operations		 -16 0.26 -43 79
Total Pre-Tax Income 		-16 0.26 -43 79
Total Revenue		 0.00 0.00 0.00 83
Net Interest Income / (Expense)		 0.00 0.00 0.00 83
Total Interest Income		 0.00 0.00 0.00 83
Total Interest Expense		 0.00 0.00 0.00 0.00
Total Non-Interest Income		 0.00 0.00 0.00 0.79
Net Realized & Unrealized Capital Gains on Investments		 0.00 0.00 0.00 -
Total Non-Interest Expense		 0.00 0.00 0.00 4.40
Nonoperating Income / (Expense), net		 -16 0.26 -43 -
Basic Earnings per Share		 $2.40 $2.30 $1.93 $1.67
Weighted Average Basic Shares Outstanding		 37.06M 35.93M 30.89M 28.48M
Diluted Earnings per Share		 $2.40 $2.30 $1.93 $1.67
Weighted Average Diluted Shares Outstanding		 37.06M 35.93M 30.89M 28.48M
Weighted Average Basic & Diluted Shares Outstanding		 37.06M 37.06M 30.89M -

Quarterly Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -17 -1.77 -1.50 4.35 7.80 0.98 1.41 -9.93 -23 -18
Consolidated Net Income / (Loss)		 -17 -1.77 -1.50 4.35 7.80 0.98 1.41 -9.93 -23 -18
Net Income / (Loss) Continuing Operations		 -17 -1.77 -1.50 4.35 7.80 0.98 1.41 -9.93 -23 -18
Total Pre-Tax Income 		-17 -1.77 -1.50 4.35 7.80 0.98 1.41 -9.93 -22 -18
Total Revenue		 -6.44 6.44 0.00 0.00 - 0.00 0.00 0.00 -19 0.00
Total Non-Interest Income		 -6.44 6.44 0.00 0.00 - 0.00 0.00 0.00 -25 0.00
Net Realized & Unrealized Capital Gains on Investments		 -6.44 6.44 0.00 0.00 - 0.00 0.00 0.00 -25 0.00
Nonoperating Income / (Expense), net		 -10 -8.22 -1.50 4.35 7.80 0.98 1.41 -9.93 - -18
Basic Earnings per Share		 $0.54 $0.64 $0.59 $0.63 $0.61 $0.59 $0.56 $0.54 $0.52 $0.52
Weighted Average Basic Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 35.93M 37.06M 37.06M 32.47M 30.89M 30.89M
Diluted Earnings per Share		 $0.54 $0.64 $0.59 $0.63 $0.61 $0.59 $0.56 $0.54 $0.52 $0.52
Weighted Average Diluted Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 35.93M 37.06M 37.06M 32.47M 30.89M 30.89M
Weighted Average Basic & Diluted Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 30.89M 30.89M

Annual Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Net Change in Cash & Equivalents		 15 7.40 -6.46 8.68
Net Cash From Operating Activities		 59 92 28 -158
Net Cash From Continuing Operating Activities		 59 92 28 -158
Net Income / (Loss) Continuing Operations		 74 84 16 84
Consolidated Net Income / (Loss)		 74 84 16 84
Amortization Expense		 -6.46 -5.17 -5.12 -8.73
Non-Cash Adjustments to Reconcile Net Income		 -10 13 8.55 -227
Changes in Operating Assets and Liabilities, net		 2.04 0.66 8.97 -5.35
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 -43 -85 -34 166
Net Cash From Continuing Financing Activities		 -43 -85 -34 166
Issuance of Debt		 347 548 339 790
Issuance of Common Equity		 0.00 0.00 0.00 53
Repayment of Debt		 -312 -565 -318 -629
Repurchase of Common Equity		 0.00 0.00 0.00 -0.52
Payment of Dividends		 -75 -65 -55 -48
Other Financing Activities, Net		 -3.43 -3.86 -0.22 0.54
Effect of Exchange Rate Changes		 -0.49 0.09 -0.01 0.01
Cash Interest Paid		 60 55 27 15
Cash Income Taxes Paid		 1.34 0.67 1.97 2.18

Quarterly Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 1.59 1.70 4.19 7.48 1.72 1.29 -13 17 -4.39 2.60
Net Cash From Operating Activities		 -2.89 47 -25 39 35 21 20 16 42 -18
Net Cash From Continuing Operating Activities		 -2.89 47 -25 39 35 21 20 16 41 -17
Net Income / (Loss) Continuing Operations		 9.99 15 20 28 31 23 23 7.78 2.60 -2.38
Consolidated Net Income / (Loss)		 9.99 15 20 28 31 23 23 7.78 2.60 -2.38
Amortization Expense		 -1.31 -1.82 -1.55 -1.79 -1.76 -1.22 -0.80 -1.38 -0.95 -0.89
Non-Cash Adjustments to Reconcile Net Income		 -14 26 -44 21 -9.29 15 -12 20 38 -13
Changes in Operating Assets and Liabilities, net		 2.07 7.28 0.04 -7.36 15 -15 11 -9.91 1.29 -1.04
Net Cash From Financing Activities		 4.97 -45 29 -32 -33 -20 -33 1.40 -47 21
Net Cash From Continuing Financing Activities		 4.97 -45 29 -32 -33 -20 -33 1.40 -47 21
Issuance of Debt		 107 55 125 60 113 233 46 156 62 98
Repayment of Debt		 -83 -82 -75 -73 -127 -235 -64 -138 -97 -62
Payment of Dividends		 -18 -19 -19 -19 -19 -18 -15 -13 -13 -14
Other Financing Activities, Net		 -1.53 - -1.90 0.00 0.01 -0.23 - -3.63 - -
Effect of Exchange Rate Changes		 -0.49 0.02 0.06 -0.07 0.10 -0.03 0.02 0.00 -0.01 -0.01
Cash Interest Paid		 13 17 13 18 12 17 12 15 7.13 9.16
Cash Income Taxes Paid		 0.08 - - 1.26 0.14 - - 0.53 - -

Annual Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Total Assets		 1,656 1,627 1,303 2,515
Cash and Due from Banks		 10 7.78 6.40 -
Restricted Cash		 29 17 11 -
Trading Account Securities		 4.82 1,587 8.15 -
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00
Other Assets		 1,600 1.46 1,268 2,515
Total Liabilities & Shareholders' Equity		 1,656 1,627 1,303 0.00
Total Liabilities		 916 885 690 0.00
Other Short-Term Payables		 3.71 3.45 5.86 -
Long-Term Debt		 876 845 654 0.00
Other Long-Term Liabilities		 21 21 18 0.00
Commitments & Contingencies		 0.00 0.00 0.00 -
Total Equity & Noncontrolling Interests		 741 743 613 0.00
Total Preferred & Common Equity		 741 743 613 0.00
Preferred Stock		 0.00 0.00 0.00 -
Total Common Equity		 741 743 613 0.00
Common Stock		 959 966 675 -
Retained Earnings		 -218 -223 -62 -

Quarterly Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 1,645 1,672 1,620 1,624 1,625 1,631 1,339
Cash and Due from Banks		 17 11 6.74 6.00 7.54 21 13
Restricted Cash		 21 25 25 17 14 13 9.41
Trading Account Securities		 1.40 2.77 4.71 8.85 7.07 7.51 -
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 1,595 23 21 28 1,584 23 1,317
Total Liabilities & Shareholders' Equity		 1,645 1,672 1,620 1,624 1,625 1,631 1,339
Total Liabilities		 896 920 869 894 899 913 717
Other Short-Term Payables		 3.76 - - - 3.24 - -
Long-Term Debt		 857 891 840 864 859 883 691
Other Long-Term Liabilities		 21 29 29 30 23 30 25
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 749 752 752 730 726 718 623
Total Preferred & Common Equity		 749 752 752 730 726 718 623
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 749 752 752 730 726 718 623
Common Stock		 966 966 966 788 788 788 666
Retained Earnings		 -217 -213 -214 -58 -63 -70 -44

Annual Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.00% -100.00% 638.18%
EBITDA Growth		 -25.05% -1.04% -107.29% 396.17%
EBIT Growth		 0.00% 0.00% -100.00% 496.17%
NOPAT Growth		 0.00% 0.00% -100.00% -21.30%
Net Income Growth		 -6,125.86% 100.61% -154.95% 44.39%
EPS Growth		 4.35% 19.17% 15.57% -7.22%
Operating Cash Flow Growth		 -36.18% 230.21% 117.73% -155.11%
Free Cash Flow Firm Growth		 90.92% -125.67% 151.23% 0.00%
Invested Capital Growth		 1.83% 25.29% -49.63% 0.00%
Revenue Q/Q Growth		 -100.00% 100.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -157.96% 93.35% 0.00% 0.00%
EBIT Q/Q Growth		 -100.00% 100.00% 0.00% 0.00%
NOPAT Q/Q Growth		 -100.00% 100.00% 0.00% 0.00%
Net Income Q/Q Growth		 -278.49% 100.36% 0.00% 0.00%
EPS Q/Q Growth		 -2.83% 4.07% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -38.89% -7.28% 121.89% 0.00%
Free Cash Flow Firm Q/Q Growth		 98.18% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.65% 6,612,903.38% 0.00% 0.00%
Profitability Metrics		 - - - -
EBITDA Margin		 0.00% 0.00% 0.00% 84.25%
EBIT Margin		 0.00% 0.00% 0.00% 94.72%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 94.72%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 0.00% 0.00% 0.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 6.28%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 6.28%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -2.14% 0.04% -14.16% 0.00%
Cash Return on Invested Capital (CROIC)		 -1.82% -22.45% 66.00% -193.72%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 3.14%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 3.14%
Return on Common Equity (ROCE)		 -2.14% 0.04% -14.16% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -2.14% 0.04% -7.08% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.00 0.00 0.00 79
NOPAT Margin		 0.00% 0.00% 0.00% 94.72%
Net Nonoperating Expense Percent (NNEP)		 1.84% -0.04% 2.74% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 5.28%
Earnings before Interest and Taxes (EBIT)		 0.00 0.00 0.00 79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.46 -5.17 -5.12 70
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.96 0.78 0.51 0.00
Price to Tangible Book Value (P/TBV)		 0.96 0.78 0.51 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 2,192.89 0.00 0.00
Dividend Yield		 10.61% 11.63% 17.55% 13.51%
Earnings Yield		 0.00% 0.05% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.96 0.88 0.75 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.29 15.14 34.07 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.76 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 1.18 1.14 1.07 0.00
Long-Term Debt to Equity		 1.18 1.14 1.07 0.00
Financial Leverage		 1.16 1.11 5.17 0.00
Leverage Ratio		 2.21 2.16 6.23 0.00
Compound Leverage Factor		 0.00 0.00 0.00 0.00
Debt to Total Capital		 54.18% 53.22% 51.65% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 54.18% 53.22% 51.65% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 45.82% 46.78% 48.35% 0.00%
Debt to EBITDA		 -135.49 -163.43 -127.92 0.00
Net Debt to EBITDA		 -129.40 -158.70 -124.59 0.00
Long-Term Debt to EBITDA		 -135.49 -163.43 -127.92 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -29 -320 1,248 -2,436
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.00 0.00 0.03
Fixed Asset Turnover		 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 1,616 1,587 1,267 2,515
Invested Capital Turnover		 0.00 0.00 0.00 0.07
Increase / (Decrease) in Invested Capital		 29 320 -1,248 2,515
Enterprise Value (EV)		 1,549 1,397 952 0.00
Market Capitalization		 712 577 315 0.00
Book Value per Share		 $19.98 $20.04 $19.83 $0.00
Tangible Book Value per Share		 $19.98 $20.04 $19.83 $0.00
Total Capital		 1,616 1,587 1,267 0.00
Total Debt		 876 845 654 0.00
Total Long-Term Debt		 876 845 654 0.00
Net Debt		 836 820 637 0.00
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 16 -0.26 43 0.00
Net Nonoperating Obligations (NNO)		 876 845 654 2,515
Total Depreciation and Amortization (D&A)		 -6.46 -5.17 -5.12 -8.73
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $2.40 $2.30 $1.93 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 37.06M 35.93M 30.89M 0.00
Adjusted Diluted Earnings per Share		 $2.40 $2.30 $1.93 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 37.06M 35.93M 30.89M 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 37.06M 37.06M 30.89M 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 0.00 0.00 0.00 55
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 66.31%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 94.72%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 -474.73% 24,543.73% -127.45% 60.46%
Augmented Payout Ratio		 -474.73% 24,543.73% -127.45% 61.12%

Quarterly Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00%
EBITDA Growth		 -340.34% 477.70% -93.38% -29.19% 88.31% 93.69% 96.05% -102.58% 0.00% 62.29%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% -100.00% 0.00% 100.00%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% -100.00% 0.00% 100.00%
Net Income Growth		 -316.93% -281.85% -206.09% 143.81% 133.41% 105.27% 107.82% -118.15% 0.00% -544.73%
EPS Growth		 -11.48% 8.47% 5.36% 16.67% 17.31% 13.46% 12.00% 38.46% 0.00% 15.56%
Operating Cash Flow Growth		 -108.35% 119.82% -221.14% 146.74% -17.31% 218.22% 390.57% 43.35% 136.78% 0.00%
Free Cash Flow Firm Growth		 89.51% -6,671,974.99% -23,525,510.03% -5,489,327.66% 0.00% 100.19% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 1.83% 6,690,663.48% 23,525,610.03% 5,489,227.66% 25.29% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 -200.00% 529.82% 0.00% -100.00% 0.00% -100.00% -100.00% 100.00% 0.00% 100.00%
EBITDA Q/Q Growth		 -267.64% 251.67% -160.48% -129.59% -43.79% -300.00% 92.92% 97.90% -1,591.69% 95.61%
EBIT Q/Q Growth		 -200.00% 529.82% -100.00% -100.00% 0.00% -100.00% 100.00% 100.00% 0.00% 100.00%
NOPAT Q/Q Growth		 -200.00% 529.82% -100.00% -100.00% 0.00% -100.00% 100.00% 100.00% 0.00% 100.00%
Net Income Q/Q Growth		 -854.60% -18.28% 0.00% -44.26% 700.21% -31.00% -97.81% 84.68% -31.72% 1.94%
EPS Q/Q Growth		 -15.63% 8.47% 0.00% 3.28% 3.39% 5.36% 3.70% 3.85% 0.00% 4.00%
Operating Cash Flow Q/Q Growth		 -106.16% 290.52% 0.00% 14.14% 62.06% 4.99% 27.05% -61.75% 331.68% -158.07%
Free Cash Flow Firm Q/Q Growth		 97.90% -144,797.96% -39,312.72% -20,467.03% -1,334,760.86% -98.00% 99.90% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.65% 603,676.02% 1,273,864.77% 26,530,182.33% 6,612,903.38% -111.43% 124.09% -462.51% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 0.00% 71.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% -27.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 108.42% 100.00%
Interest Burden Percent		 262.69% -27.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 152.73% 0.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 1.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -2.14% 1.70% 0.00% 0.00% 0.04% 0.00% 0.00% 0.00% -14.16% 0.00%
Cash Return on Invested Capital (CROIC)		 -1.82% -99.45% 1.41% -99.09% -22.45% 0.00% 0.00% 0.00% 98.52% 0.00%
Operating Return on Assets (OROA)		 0.00% 2.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% -0.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -2.14% 1.70% 0.00% 0.00% 0.04% 0.00% 0.00% 0.00% -14.16% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 1.19% 1.55% 1.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.51 4.51 0.00 0.00 0.00 0.00 0.00 0.00 -15 0.00
NOPAT Margin		 0.00% 70.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 1.44% 1.47% 0.34% -1.04% -1.04% 8,123.44% -40,454.40% -68,461.49% 1.26% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -6.44 6.44 0.00 0.00 0.00 0.00 0.00 0.00 -14 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -7.75 4.62 -1.55 -1.79 -1.76 -1.22 -0.80 -1.38 -15 -0.89
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.96 0.89 0.00 0.78 0.78 0.00 0.00 0.00 0.51 0.00
Price to Tangible Book Value (P/TBV)		 0.96 0.89 0.00 0.78 0.78 0.00 0.00 0.00 0.51 0.00
Price to Revenue (P/Rev)		 0.00 37.00 0.00 2,242.77 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 75.30 0.00 40.57 2,192.89 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 10.61% 11.36% 11.39% 12.00% 11.63% 11.56% 13.20% 15.54% 17.55% 15.86%
Earnings Yield		 0.00% 1.33% 0.00% 2.46% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.96 0.93 0.00 0.88 0.88 0.00 67,909.39 0.00 0.75 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 82.34 0.00 5,315.82 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 133.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 82.34 0.00 5,315.82 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 167.58 0.00 96.16 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 26.29 15.44 0.00 12.07 15.14 5.54 7.89 10.54 34.07 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.18 1.14 1.18 1.12 1.14 0.00 0.00 0.00 1.07 0.00
Long-Term Debt to Equity		 1.18 1.14 1.18 1.12 1.14 0.00 0.00 0.00 1.07 0.00
Financial Leverage		 1.16 1.14 1.18 1.12 1.11 0.00 0.00 0.00 1.07 0.00
Leverage Ratio		 2.21 2.20 2.22 2.16 2.16 0.00 0.00 0.00 6.23 0.00
Compound Leverage Factor		 5.82 -0.60 0.00 0.00 0.00 0.00 0.00 0.00 9.52 0.00
Debt to Total Capital		 54.18% 53.38% 54.21% 52.78% 53.22% 100.00% 100.00% 100.00% 51.65% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 54.18% 53.38% 54.21% 52.78% 53.22% 100.00% 100.00% 100.00% 51.65% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 45.82% 46.62% 45.79% 47.22% 46.78% 0.00% 0.00% 0.00% 48.35% 0.00%
Debt to EBITDA		 -135.49 76.86 167.92 -158.22 -163.43 0.00 0.00 0.00 -127.92 0.00
Net Debt to EBITDA		 -129.40 73.47 161.11 -152.21 -158.70 0.00 0.00 0.00 -124.59 0.00
Long-Term Debt to EBITDA		 -135.49 76.86 167.92 -158.22 -163.43 0.00 0.00 0.00 -127.92 0.00
Debt to NOPAT		 0.00 96.55 76.63 57.79 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 92.29 73.52 55.59 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 96.55 76.63 57.79 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -34 -1,602 -1,643 -1,592 -320 0.02 -0.01 0.03 0.00 0.00
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 1,616 1,606 1,643 1,592 1,587 -0.02 0.01 -0.03 1,267 0.00
Invested Capital Turnover		 0.00 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 29 1,606 1,643 1,592 320 -0.02 0.01 -0.03 0.00 0.00
Enterprise Value (EV)		 1,549 1,488 0.00 1,398 1,397 551 474 346 952 0.00
Market Capitalization		 712 669 0.00 590 577 551 474 346 315 0.00
Book Value per Share		 $19.98 $20.20 $20.30 $20.28 $20.04 $0.00 $0.00 $0.00 $19.83 $0.00
Tangible Book Value per Share		 $19.98 $20.20 $20.30 $20.28 $20.04 $0.00 $0.00 $0.00 $19.83 $0.00
Total Capital		 1,616 1,606 1,643 1,592 1,587 -0.06 -0.06 -0.12 1,267 0.00
Total Debt		 876 857 891 840 845 -0.06 -0.06 -0.12 654 0.00
Total Long-Term Debt		 876 857 891 840 845 -0.06 -0.06 -0.12 654 0.00
Net Debt		 836 819 855 808 820 -0.06 -0.06 -0.12 637 0.00
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 12 6.28 1.50 -4.35 -7.80 -0.98 -1.41 9.93 8.28 18
Net Nonoperating Obligations (NNO)		 876 857 891 840 845 -0.02 0.01 -0.03 654 0.00
Total Depreciation and Amortization (D&A)		 -1.31 -1.82 -1.55 -1.79 -1.76 -1.22 -0.80 -1.38 -0.95 -0.89
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.54 $0.64 $0.59 $0.63 $0.61 $0.59 $0.56 $0.54 $0.52 $0.52
Adjusted Weighted Average Basic Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 35.93M 37.06M 37.06M 32.47M 30.89M 30.89M
Adjusted Diluted Earnings per Share		 $0.54 $0.64 $0.59 $0.63 $0.61 $0.59 $0.56 $0.54 $0.52 $0.52
Adjusted Weighted Average Diluted Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 35.93M 37.06M 37.06M 32.47M 30.89M 30.89M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.24 $0.00 ($0.08)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 30.89M 30.89M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.51 4.51 0.00 0.00 0.00 0.00 0.00 0.00 -15 0.00
Normalized NOPAT Margin		 0.00% 70.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% -27.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -474.73% 851.51% 643.88% 486.88% 24,543.73% -81.14% -315.91% -48.29% -127.45% 0.00%
Augmented Payout Ratio		 -474.73% 851.51% 643.88% 486.88% 24,543.73% -81.14% -315.91% -48.29% -127.45% 0.00%

Frequently Asked Questions About Crescent Capital BDC's Financials

When does Crescent Capital BDC's fiscal year end?

According to the most recent income statement we have on file, Crescent Capital BDC's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Crescent Capital BDC's net income changed over the last 3 years?

Crescent Capital BDC's net income appears to be on a downward trend, with a most recent value of -$15.85 million in 2024, falling from $78.94 million in 2021. The previous period was $263 thousand in 2023. See Crescent Capital BDC's forecast for analyst expectations on what’s next for the company.

How has Crescent Capital BDC revenue changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's total revenue changed from $83.34 million in 2021 to $0.00 in 2024, a change of -100.0%.

How much debt does Crescent Capital BDC have?

Crescent Capital BDC's total liabilities were at $915.64 million at the end of 2024, a 3.5% increase from 2023, and a 91,563,700,000.0% increase since 2021.

How much cash does Crescent Capital BDC have?

In the past 3 years, Crescent Capital BDC's cash and equivalents has ranged from $0.00 in 2021 to $10.13 million in 2024, and is currently $10.13 million as of their latest financial filing in 2024.

How has Crescent Capital BDC's book value per share changed over the last 3 years?

Over the last 3 years, Crescent Capital BDC's book value per share changed from 0.00 in 2021 to 19.98 in 2024, a change of 1,998.4%.


Related Companies

This page (NASDAQ:CCAP) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...
The Tomorrow Investor | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
The biggest threat isn’t China
While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...
True Market Insiders | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
The trade war twist nobody saw coming
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...
Porter & Company | Sponsored